Newsletters

07.22.19

Update on Drug Pricing Transparency: What’s Next?

On July 9, Judge Amit P. Mehta of the U.S. District Court, District of Columbia vacated an administration final rule that would have required drug manufacturers to disclose wholesale acquisition prices in their television broadcast advertising.


07.22.19

Sweepstakes and Contests: What Healthcare Organizations Need to Know

Before addressing legal requirements and compliance practices, it is important to understand the terminology used in discussing prize promotions.


07.22.19

New Webinar: New Opportunities to Advance Integrated Care for Dual Eligibles

Dual eligibles—those eligible for both Medicare and Medicaid—are among the most costly and complex enrollees in both programs.


07.09.19

Medicare Part D Out-of-Pocket Caps and Enrollee Spending

High out-of-pocket costs can be a significant barrier to access for Part D enrollees, especially for non-low-income subsidy (LIS) enrollees with a condition that requires an expensive specialty drug for treatment.


06.28.19

Utah Seeks Capped Spending, Partial Expansion with Enhanced Match

On May 31, 2019, Utah released a draft Section 1115 waiver application, the Per Capita Cap Demonstration, for public comment.


06.25.19

The Final Rule’s Impact on Drug Pricing Transparency

In May 2018, the President and the Department of Health & Human Services (HHS) rolled out the Drug Pricing Blueprint, outlining the administration’s agenda for dealing with high drug prices.


06.25.19

Health Plan Transactions: Trends and Issues

There have been a number of health plan transactions over the past year, but we’ve seen a shift in the types of deals.


06.25.19

Massive Data Breach Underscores Importance of Business Associate Security

It is no surprise that healthcare data breaches are on the rise.


06.25.19

Influencer and Content Marketing: Challenges and Opportunities for Healthcare

On May 23, the bipartisan leadership of the House Ways and Means Committee released a four-page draft discussion bill that, if enacted, would make the most significant changes to the Part D benefit since the Affordable Care Act’s changes to the coverage gap.


06.25.19

Best Practices and Next Steps in the Opioid Epidemic

Mississippi’s opioid epidemic is following national trends.